Adaptimmune Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADAP and other ETFs, options, and stocks.About ADAP
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8.
CEOAdrian Rawcliffe
CEOAdrian Rawcliffe
Employees449
Employees449
HeadquartersAbingdon, Oxfordshire
HeadquartersAbingdon, Oxfordshire
Founded2008
Founded2008
Employees449
Employees449
ADAP Key Statistics
Market cap285.11M
Market cap285.11M
Price-Earnings ratio-3.21
Price-Earnings ratio-3.21
Dividend yield—
Dividend yield—
Average volume1.22M
Average volume1.22M
High today$1.19
High today$1.19
Low today$1.09
Low today$1.09
Open price$1.17
Open price$1.17
Volume1.52M
Volume1.52M
52 Week high$2.05
52 Week high$2.05
52 Week low$0.42
52 Week low$0.42
Analyst ratings
70%
of 10 ratingsBuy
70%
Hold
20%
Sell
10%